Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.

Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M.

Nat Immunol. 2009 Nov;10(11):1178-84. doi: 10.1038/ni.1791. Epub 2009 Sep 27.

2.

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK.

Nat Immunol. 2008 Dec;9(12):1347-55. doi: 10.1038/ni.1677. Epub 2008 Nov 9. Erratum in: Nat Immunol. 2009 May;10(5):551.

3.

The gut feeling of Treg cells: IL-10 is the silver lining during colitis.

Unutmaz D, Pulendran B.

Nat Immunol. 2009 Nov;10(11):1141-3. doi: 10.1038/ni1109-1141.

PMID:
19841645
4.

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Round JL, Mazmanian SK.

Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9. doi: 10.1073/pnas.0909122107. Epub 2010 Jun 21.

5.

Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.

Kamanaka M, Huber S, Zenewicz LA, Gagliani N, Rathinam C, O'Connor W Jr, Wan YY, Nakae S, Iwakura Y, Hao L, Flavell RA.

J Exp Med. 2011 May 9;208(5):1027-40. doi: 10.1084/jem.20102149. Epub 2011 Apr 25.

6.

Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.

Feng T, Cao AT, Weaver CT, Elson CO, Cong Y.

Gastroenterology. 2011 Jun;140(7):2031-43. doi: 10.1053/j.gastro.2011.03.009. Epub 2011 Mar 17.

7.

Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.

Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT.

Nat Immunol. 2007 Sep;8(9):931-41. Epub 2007 Aug 12.

PMID:
17694059
8.

Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice.

Lee SE, Li X, Kim JC, Lee J, González-Navajas JM, Hong SH, Park IK, Rhee JH, Raz E.

Gastroenterology. 2012 Jul;143(1):145-54. doi: 10.1053/j.gastro.2012.03.042. Epub 2012 Apr 1. Erratum in: Gastroenterology. 2013 May;144(5):1157.

9.

Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.

Yao Y, Vent-Schmidt J, McGeough MD, Wong M, Hoffman HM, Steiner TS, Levings MK.

J Immunol. 2015 Jul 15;195(2):488-97. doi: 10.4049/jimmunol.1403225. Epub 2015 Jun 8.

10.

TNFRp55 controls regulatory T cell responses in Yersinia-induced reactive arthritis.

Cargnelutti E, Arias JL, Valdez SR, Rabinovich GA, Di Genaro MS.

Immunol Cell Biol. 2013 Feb;91(2):159-66. doi: 10.1038/icb.2012.65. Epub 2012 Dec 4.

PMID:
23207279
11.

Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells.

Won HY, Jang EJ, Lee K, Oh S, Kim HK, Woo HA, Kang SW, Yu DY, Rhee SG, Hwang ES.

J Immunol. 2013 Oct 15;191(8):4029-37. doi: 10.4049/jimmunol.1203247. Epub 2013 Sep 18.

12.
13.

CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.

Yurchenko E, Levings MK, Piccirillo CA.

Eur J Immunol. 2011 Dec;41(12):3455-66. doi: 10.1002/eji.201141814. Epub 2011 Nov 10.

14.

CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.

Liu T, Soong L, Liu G, König R, Chopra AK.

Biol Direct. 2009 Oct 23;4:40. doi: 10.1186/1745-6150-4-40.

15.

Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.

Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, Olivier M, Piccirillo CA.

PLoS One. 2012;7(4):e35572. doi: 10.1371/journal.pone.0035572. Epub 2012 Apr 24.

16.

A central role for induced regulatory T cells in tolerance induction in experimental colitis.

Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, Carlson MR, Li SH, Simpson PM, Chatila TA, Williams CB.

J Immunol. 2009 Mar 15;182(6):3461-8. doi: 10.4049/jimmunol.0802535.

17.

Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.

Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F.

J Immunol. 2006 Nov 1;177(9):5852-60.

18.

Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells.

Maynard CL, Hatton RD, Helms WS, Oliver JR, Stephensen CB, Weaver CT.

J Exp Med. 2009 Feb 16;206(2):343-57. doi: 10.1084/jem.20080950. Epub 2009 Feb 9.

19.

IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.

Fantini MC, Rizzo A, Fina D, Caruso R, Becker C, Neurath MF, Macdonald TT, Pallone F, Monteleone G.

Eur J Immunol. 2007 Nov;37(11):3155-63.

20.

CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.

Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH.

J Immunol. 2012 Feb 15;188(4):2001-13. doi: 10.4049/jimmunol.1100765. Epub 2012 Jan 16.

Supplemental Content

Support Center